Sidoti Csr Brokers Raise Earnings Estimates for USNA

USANA Health Sciences, Inc. (NYSE:USNA) – Investment analysts at Sidoti Csr raised their Q1 2025 EPS estimates for USANA Health Sciences in a report released on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now expects that the company will earn $0.84 per share for the quarter, up from their prior estimate of $0.73. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.74 EPS, Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $3.09 EPS and FY2026 earnings at $3.63 EPS.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter in the prior year, the firm earned $0.59 EPS.

Several other brokerages have also recently weighed in on USNA. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Thursday, December 19th. DA Davidson upgraded shares of USANA Health Sciences to a “hold” rating in a report on Friday, December 20th.

USANA Health Sciences Price Performance

Shares of USNA opened at $35.69 on Friday. The stock has a market capitalization of $680.25 million, a price-to-earnings ratio of 12.61, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a 1 year low of $31.44 and a 1 year high of $54.81. The business’s 50 day simple moving average is $37.88 and its 200-day simple moving average is $40.01.

Hedge Funds Weigh In On USANA Health Sciences

Institutional investors have recently modified their holdings of the stock. Pzena Investment Management LLC lifted its position in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after acquiring an additional 72,977 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of USANA Health Sciences by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock worth $30,907,000 after purchasing an additional 3,889 shares in the last quarter. Pacer Advisors Inc. lifted its holdings in shares of USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after purchasing an additional 76,904 shares during the last quarter. State Street Corp boosted its position in shares of USANA Health Sciences by 0.6% in the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after purchasing an additional 2,782 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in USANA Health Sciences by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock worth $11,269,000 after buying an additional 12,898 shares during the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.